16:00-17:00 CET (Brussels time zone)

The Capital Markets and ESG: Insights from the Biopharma Investor ESG Communications Initiative

By Ms. Myrto Kontaxi (Sustainability & ESG Advisor, Partner of the Biopharma Sustainability Roundtable)

Location: Hybrid

  • Ms. Myrto Kontaxi

    Ms. Myrto Kontaxi

    Sustainability and ESG Advisor, Partner of the Biopharma Sustainability Roundtable

– Sustainability, ESG, and Impact in the capital markets universe

– The Biopharma Investor ESG Communications Initiative, a brief overview

– Investor objectives and expectations from business

– Business and investor ESG communications: The role of other capital markets stakeholders (i.e. raters, standard-setters)

Social Share

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close